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Abstract:  
The parasite Giardia lamblia is known to cause the disease giardiasis, which is a major threat 
against the public health, especially in developing countries. A recent study has shown that 
over 200 million people have giardiasis now, and about 500 000 more people are infected 
every year. A G. lamblia infection is usually treated with the drugs metronidazole, 
albendazole, tinidazole and furazolidone. These drugs are in some cases toxic and have severe 
side effects. Therefore new methods of killing the parasite are of great importance. Ribose-5-
phosphate isomerase (Rpi) is an enzyme active in the pentose phosphate pathway, and it 
catalyses the conversion of ribose 5-phosphate to ribulose 5-phosphate and vice versa. Some 
enzymes in this class can also act on 6-carbon substrates, interconverting allose 6-phosphate 
and allulose 6-phosphate. To find which inhibitor works best on the enzyme from G. lamblia 
(GlRpiB), the enzyme was expressed as a His-tagged construct in E. coli was purified then 
tested to check its purity. When it was confirmed to be the right protein, the protein was used 
for crystallization and kinetic assays. Allose-6-phosphate was added before crystallization. 
Crystals formed in the presence of allose-6-phosphate. The Km, Vmax and kcat were determined 
and inhibitory tests were performed. It was determined that the Km for ribose-5-phosphate is 
about 10 mM, and the kcat is around 260sec-1. The Km of for allose-6-phosphate is 0.41 mM, 
and kcat 0.008sec-1. Among 6 substrate-like compounds tested, only 4PEH (4-phospho-D-
erythronohydroxamic acid) showed significant inhibition of GlRpiB. 
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Introduction 
 
Giardia lamblia is a pear-shaped eukaryotic unicellular flagellated parasite. The first time G. 
lamblia was described was in 1681 by van Leeuwenhoek. The parasite was characterized in 
greater detail in 1859 by Lambl. The parasite differs from other eukaryotes by not having any 
classical mitochondria or cytochrome-mediated oxidative phosphorylation. Instead, the 
parasite has a mitosome, which has homologous proteins to mitochondria, suggesting a 
mitochondrial ancestry (S. Svard et al 2010). These facts indicate that the parasites use 
fermentative metabolism. G. lamblia is the most commonly detected parasite in human and 
mammalian intestinal tracts in the world (Adam 2001). It is known to cause the disease 
giardiasis, which is a major threat against the public health in developing countries (Tian 
2010). It has also been proved that the Giardia parasite can jump between dogs and humans, 
if both live in the same location (Traube et a.  2004). A recent study has shown that over 200 
million people now suffer from giardiasis, and about 500 000 more people are infected every 
year.  
 
The Giardia life cycle is made up of an infective cyst and a vegetative trophozoite. The 
vegetative trophozoite is pear-shaped and about 12-15 μm long. The trophozoite has two 
nuclei that are similar in appearance and function, as they are replicated at the same time and 
transcriptionally active. The infective cyst has an inner double membrane layer and an outer 
filamentous layer that is made up from N-acetylgalactosamine. In contrast to the trophozoite, 
the cyst has four nuclei. G. lamblia has like most eukaryotes, linear chromosomes with 
telomeres on the edges. Sequencing of the genome has shown a very high G-C content (Adam 
2001).     
 
One is infected by ingesting the infective cyst, while the trophozoite causes the asymptomatic 
infection. When a cyst comes into contact with the hydrochloric acid in the stomach, the outer 
filamentous layer breaks down and the cyst forms the trophozoite, which then moves into the 
small intestine. The trophozoite attaches to the intestinal wall by a ventral adhesive disk. This 
disk is a unique feature for G. lamblia, and is very important for the survival of the parasite, 
as no cellular invasion or receptor mediated adhesion has been reported. The disk has a 
concave shape and spans the whole ventral surface of the parasite. In the disk the proteins 
actin, myosin and topomyosin are found, which are needed for contraction. After the parasite 
has attached itself to the intestinal wall, it starts to take nutrients from the host and replicate. 
When the body flushes the small intestine with biliary fluid, some of the trophozoites form 
cysts which move into the jejunum with the biliary fluid and exit the host with the feces. The 
cysts can now infect a new host, thus completing the transmission cycle (Adam 2001). 
Symptoms start to appear two weeks after infection, and last for two to five days. Giardia 
infection usually does not cause a long lasting infection in people without immunodeficiency. 
Persons who have an immunodeficiency are more likely to suffer from a chronic infection, 
and in combination with starvation it is highly lethal. There have been cases of people without 
immunodeficiency who have suffered from a chronic infection with Giardia (Rivero et 
al.2010). A G. lamblia infection is usually treated with the drugs metronidazole, albendazole, 
tinidazole and furazolidone. These drugs are in some cases toxic and may have severe side 
effects (Tian 2010). Therefore a new method of killing the parasite would be of great 
importance.  
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Figure 1. Picture showing the life cycle of G. lamblia with trophozoites attached to epithelial cells by the 
adhesive disk at the bottom of the picture and the infective cyst at the top of the picture (S. Svard et al 2010).        
 
Ribose-5-phosphate isomerase (Rpi) is an enzyme active in the pentose phosphate pathway 
and it catalyses the conversion of ribose-5-phosphate to ribulose-5-phosphate and vice versa 
(Rose et al 2005). One important product of the pentose phosphate pathway is NADPH, 
which is used as a reductive agent in biological reactions. The pathway is also used to 
synthesize nucleic acids and other important biochemical compounds (Berg et al 2006). There 
are two completely unrelated types of Rpi: A and B. The two types of proteins have evolved 
convergently which means that they have different evolutionary ancestors but perform the 
same biochemical reaction. In agreement with the sequence information, the two types of Rpi 
have completely different structures, and their active sites show very little similarity. Humans 
have the A type of Rpi, while Giardia has the B type, which makes GlRpiB a perfect 
candidate for a drug target, as a drug could be designed to inhibit the B type but not the A 
type, thus killing the parasite but not the patient (Stern et al 2006). GlRpiB has a molecular 
weight 17804 Da in the construct with a His-tag and an isoeletric point of 6.5.  
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Materials and Methods  
 
All calculations and buffer recipes can be found in the Appendix. 
Expression of protein 
Protein was induced and expressed as a His-tagged construct (A. Stern, unpublished data) by 
using homemade chemically competent BL21-AI E. coli cells (Invitrogen). A cell culture was 
started from a single colony in LB medium containing 100μg/ml of ampicilin. After overnight 
incubation the culture was diluted 1/50 in 800ml of fresh LB medium containing 100μg/ml of 
ampicilin. Three hours later the protein expression was induced using 0.02g/L of arabinose in 
the first expression and 0.2g/L of arabinose in the second expression for three hours. Cells 
were collected by centrifugation and stored at -20oC.   
Protein purification 
To the bacterial pellet from the 800 ml of culture, 20 ml of lysis buffer was added to break up 
the cells which enable extraction of the expressed protein. The culture was run through a cell 
disruptor to make sure every cell was fully destroyed. The solution of disrupted cells was then 
centrifuged at maximum speed until the supernatant was clear. A nickel column was used to 
extract GlRpiB from the solution of disrupted cells. The gene incorporated into the expression 
vector used had a His-tag sequence, which made it stick to the column while other proteins 
without a His-tag pass through the column. When the column is washed with imidazole-
containing elution buffer, the interaction between the metal and the His-tag is broken and the 
protein is eluted. The nickel column used was a Ni Sepharose High Performance column sold 
by GE Healthcare. The column was first washed with distilled water and then equilibrated 
with lysis buffer. The supernatant was poured into the top of the column. When the 
supernatant has passed through the column and collected at the bottom, non-bound proteins 
were eluted with lysis buffer and collected. The column was then washed with wash buffer 1 
and the eluate was collected. The same process was repeated with wash buffer 2. Finally, 
GlRpiB was eluted with elution buffer and the eluate was collected. 
Concentration of protein 
All fractions containing protein were analyzed by SDS-PAGE, and fractions containing the 
protein with the predicted molecular weight of GlRpiB were concentrated by a Vivaspin kit 
with a 5000 Da cut-off.  
   
Measuring protein concentration 
To know accurate protein concentration is important for kinetics, where accurate values are 
needed to get accurate kinetic values. The protein concentration was measured using a 
spectrophotometer and the Bradford method, calibrated with BSA (bovine serum albumin) 
provided with the Bradford reagents. In the Bradford method the absorbance (at 595nm) is 
divided with the Bradford factor which in this case is 0.04 μg/ml (obtained from the 
calibration with BSA). The Bradford method is linear till the region 10 μg -20 μg and 
measurements outside the linear face may not be accurate. 
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Gel filtration experiments  
To verify that the product is of the right size and to investigate it aggregation state as well to 
purify the sample further, a HiLoad Superdex 75 preparative grade gel filtration column was 
used and followed according to the manufacturer’s instructions. The column had a flow rate 
of 1ml/min and a column volume of 120.6 ml. The column was calibrated with the proteins 
ribonuclease A (15600 Da), Chymotrypsinogen A (20400 Da), Ovoalbumin (48100 Da) and 
Albumin (63500 Da). The buffer used was the gel filtration buffer. All fractions eluted from 
the column were collected.  
 
Measurement of protein size and purity 
To follow the purification process and make sure the expressed protein is of the right size, a 
SDS-PAGE was performed. The Phast system was used and followed according to the 
manufacturer’s instructions. For the fractions from the gel filtration chromatography, 1 μl of 
fraction was mixed with 5 μl of 6x SDS buffer. From the eluted fractions collected when the 
nickel column was washed with wash buffer 1 and wash buffer 2 2.5 μl of sample was taken 
and mixed with 1 μl 6x SDS buffer. From the soluble and insoluble crude extracts, and the 
flowthrough from the nickel column, 1μl was mixed with 4 μl of distilled water and 1 μl of 6x 
SDS buffer. All the samples were heated at 95oC for 20 seconds and then applied to the SDS-
PAGE gel. A native gel was also performed to get an understanding of the protein’s behavior 
when it is not denatured by SDS, and to see if this differs with substrate bound. 1.5 μl of 4 
mg/ml protein in cacodylate buffer in pH 7.5, 6.5 and 5 were mixed with 1 μl of 5mM of 
ribose-5-phosphate, 1 μl of loading buffer and 2.5 μl of distilled water.  
 
Crystallization 
Crystallization of protein is essential when solving the structure of any protein by x-ray 
crystallography. In the crystal, all the protein molecules are aligned in the same direction so 
that when the crystal is hit by x-rays, the scattered x-rays will form a specific pattern on an x-
ray detection plate. The spot pattern is used to solve the structure of the protein provided that 
some method of obtaining the correct phases is available. The crystallization plates used were 
MRC-2 plates from Hampton Research with different commercially available screens. The 
first screen set up was an optimum solubility screen, to see under what conditions the protein 
would precipitate. Those conditions are important to avoid because crystals are formed from 
initially clear drops. The screens after the optimum solubility screen had different buffers in 
which the protein would crystallize, as well as different precipitants. The plates and screens 
were set up using a Douglas Instruments Oryx 8 protein crystallization robot.  
Kinetics  
To be able to test potential inhibitors, one must be confident in the protein’s Km, Vmax and kcat 
values. In a kinetic test, a known concentration of substrate is added to the protein and the 
amount of product is measured as a function of time. Two different types of substrates were 
used: 
 
Ribose 5-phosphate  
The protein was diluted 1:41500 which gave a concentration of 0.002 mg/ml (1.14 * 10-4mM) 
from the original 83 mg/ml. 80 μl Tris buffer was mixed with 10 μl of substrate in a cuvette 
and incubated for 5 minutes. After the incubation, 10 μl enzyme solution was added to the 
 9
cuvette which gave a final enzyme concentration of 0.0002mg/ml, and the increase in 
absorbance at 290 nm was measured for 180 seconds.  
 
Allose 6-phosphate 
The assay is based on the kinetic assay of Laurent Salmon et. al (2004). Incubation buffer and 
allose 6-phosphate were placed in 1.5 ml tubes, and 10 μl of enzyme was added to the tube to 
initialize the reaction. The tubes were placed at 26oC for 10 and 20 minutes.100 μl of HCl was 
added to each test tube to stop the reaction, after which 100 μl of TBA (thiobarbituric acid)-
HCl solution (20 mM) was added to each test tube to bind to the product (allulose 6-
phosphate). All test tubes were heated at 80oC for 6 minutes to convert the product and the 
TBA to a second product, which absorbs light. The tubes were placed on ice for 20 seconds to 
stop all activity in the test tubes. The tubes were incubated at room temperature for one hour. 
The absorbance at 438 nm was measured. The absorbance was considered as a change over 
time where the initial time and absorbance is assumed to be the moment the substrate and 
enzyme were mixed in the cuvette. 
Inhibitor tests 
70 μl Tris buffer pH 7.5 was mixed with 10 μl of ribose-5-phosphate with a final 
concentration of 5mM and 10 μl of inhibitor with a final concentration of 10mM in a cuvette 
and incubated for 5 minutes. After the incubation, 10 μl enzyme was added to the cuvette. The 
final concentration of enzyme in the cuvette was 1.8 μM. The change in absorbance at 290 nm 
for 180 seconds was measured at room temperature. All samples with inhibitor were repeated 
in triplicate. Samples containing 80 μl Tris buffer at pH 7.5 was mixed with 10 μl of substrate 
in a cuvette and incubated for 5 minutes. After the incubation, 10 μl enzyme was added to the 
cuvette. This was done to see what the change in absorbance was when there was no inhibitor 
present. If the triplets with inhibitor have a lower change in absorbance than the triplets 
without the inhibitor, the inhibitor works. 
 
     Figure 2. Picture showing the name and the structure of the four-carbon inhibitors. 
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Figure 3. Picture showing the name and the structure of the five-carbon inhibitors. 
 
Results  
 
All calculations and buffer recipes can be found in the appendix.  
Final concentration of protein and estimation of yield 
 
First purification 
For concentration of the protein with a Vivaspin column, fractions 22-25 (see Figure 2) from 
the gel filtration chromatography were pooled, as they most likely had the highest amount of 
the protein of interest amongst the fractions, this because of the height of the peak and the 
molecular weight of the protein that represented the peak on the gel chromatogram. To 
measure the concentration of protein the Bradford method was used, calibrated with BSA. 
The solution gave an absorbance of 0.733, which corresponds to an initial concentration of 83 
mg/ml. This gives a yield of 20mg protein/L of cell culture.  
 
Second purification 
For concentration of the protein with a Vivaspin column, fractions B12-B14 (see Figure 3) 
from the gel filtration chromatography were used as they most likely had the highest amount 
of the protein of interest amongst the fractions because of the height of the peak and the 
molecular weight of the protein that represented the peak on the gel chromatogram. After the 
purification and during the concentration of protein, the protein solution was placed in two 
separate 20ml Falcon tubes one with cacodylate buffer in pH 7.0 and the other tube with 
cacodylate buffer in pH 6. The absorbance of the sample at pH 7.0 was 0.342 using the 
Bradford method, corresponding to 86 mg/ml protein in the concentrated sample and a yield 
of 42.5mg of protein/L of cell culture. The absorbance of the sample at pH 6.0 was 0.114 
corresponding to 29 mg/ml after concentration and a yield of 14 mg of protein/L of culture.  
Gel filtration chromatography  
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Figure 4. Gel chromatography graph from the second purification showing two peaks. The x-axis displays the 
elution volumes and the fraction numbers which are show in red numbers. The y-axis displays the mAu scale.   
 
In Figure 4, two peaks are seen with different heights. The larger peak has an elution volume 
of 63.9 ml while the smaller peak has an elution volume of 50.0 ml. The Kav for the large peak 
was calculated to be 0.2636. By using a standard curve for the gel filtration column, the log of 
the molecular weight of the large peak was calculated to be 4.5 which gives a molecular 
weight of 33,8 kDa. The Kav for the small peak was calculated to be 0.0831, which is outside 
the calibration range and therefore the small peak represents a protein that is larger then the 
biggest protein used to calibrate the column (Albumin, 63500 Da).  
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Figure 5. Gel chromatogram from the second purification showing two peaks. The x-axis displays the elution 
volumes and the fraction numbers, which are shown in red. The y-axis displays the absorbance scale in units of 
mAu. 
 
In Figure 5, two peaks are seen with different mAu values. There is a large difference in the 
mAu values between the two peaks. The smaller peak has an elution volume of 44.5ml while 
the large peak has an elution volume of 58.8ml. The smaller peak has a Kav value of 0.0116, 
which is outside the calibration range and therefore the small peak represents a protein that is 
larger then the biggest protein used to calibrate the column (Albumin, 63500 Da).  
The larger peak has a Kav value of 0.191. By using a standard curve for the gel filtration 
column the log of the molecular weight was calculated to be 4.66 which give a molecular 
weight of 45.7 kDa. 
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Verification of protein size by SDS-PAGE 
 
 
Figure 6. SDS-PAGE gel showing different fractions and eluates from the first protein purification. Lane 1 
contains fraction 18 from the first gel filtration chromatography (see Figure 4). Lane 2 contains fraction 17 from 
the first gel filtration chromatography (see Figure 4).  Lane 3 contains the insoluble crude extract. Lane 4 
contains the second wash of the nickel column. Lane 5 contains the flowthrough  from the nickel column. Lane 6 
contains the crude soluble extract. Lane 7 contains the first wash of the nickel column. Lane 8 contains a Low 
Molecular Weight marker in kDa. The gel gradient is 8-25% acrylamide 
 
97.0 
 
66.0 
 
45.0 
 
 
30.0 
 
20.1 
 
 
14.4 
 
 
    1         2         3            4           5          6           7            8         
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Figure 7. SDS-PAGE gel showing different fractions from the first gel filtration chromatography experiment 
(see Figure 4). Lanes 1 to 6 contain fractions in the order 25 to 20. Lane 7 contains a Low Molecular Weight 
marker in kDa. Lane 8 contains fraction 19. The gel gradient is 8-25% acrylamide.  
 
  
Figure 8. SDS-PAGE gel showing different fractions from the first gel filtration chromatography (see Figure 4). 
Lane 1 contains fraction 26. Lane 2 contains fraction 27. Lane three contains a Low Molecular Weight marker, 
with sizes marked in kDa. The gel gradient is 8-25% acrylamide.  
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As seen in Figure 6, there are clear bands at the right size for the monomer of G. lamblia 
ribose-5-phosphate isomerase B in lanes the following fractions: the second wash of the 
nickel column, the flowthrough  from the nickel column and in the crude soluble extract. The 
fraction from the first wash of the nickel column shows a weak band at the right size for the 
protein. Fractions 18 and 17 from the gel filtration chromatography experiment (see figure 4) 
show no visible product. The SDS-PAGE gel in Figure 7 has strong bands at the right size in 
the fractions 25, 24, 23 and 22 from the gel filtration chromatography experiment (see figure 
4). Fraction 21 has a weak band at the right size while fraction 20 and 19 do not have any 
visible product. In Figure 8 there are bands at the right size in lanes with fraction 26 and 27 
from the gel filtration experiment (see figure 4) but the band in the lane containing fraction 26 
is much more intense than the lane containing fraction 27.        
 
 
Figure 9. SDS-PAGE gel showing the different eluates from the second purification.  Lane 1 contains the eluate 
from the nickel column collected when the column was washed with the elution buffer. Lane 2 contains 4μg/μl 
of protein kept in a buffer with a pH of 7.5. Lane 3 contains the flowthrough from the nickel column. Lane 4 
contains the insoluble crude extract from the protein purification. Lane 5 contains the soluble crude extract from 
the protein purification. Lane 6 contains the eluate from the nickel column when it was washed with the second 
wash buffer. Lane 7 contains the eluate collected from the nickel column when it was washed with the first wash 
buffer. Lane eight contains a Low Molecular Weight marker, with sizes marked in kDa. The gel was a 
homogenous 20% acrylamide gel.     
 
As seen in Figure 9, there are strong bands at the right size for G. lamblia ribose-5-phosphate 
isomerase B in lanes with product from eluate from the nickel column collected when the 
column was washed with elution buffer, 4μg/μl of protein kept in a buffer with a pH of 7.5, 
soluble crude extract from the protein purification, and the eluate collected from the nickel 
column when it was washed with the second wash buffer. There are weaker bands at the right 
size in lanes with the flowthrough from the nickel column, the insoluble crude extract from 
the protein purification and the eluate collected from the nickel column when it was washed 
with the first wash buffer.   
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Figure 10. A native gel with samples kept at different pHs. Lane 1 contains RpiB kept in cacodylate buffer of pH 
5.0 with ribose-5-phosphate. Lane 2 contains RpiB kept in cacodylate buffer of pH 6.5 with ribose-5-phosphate. 
Lane 3 contains RpiB kept in cacodylate buffer of pH 7.5 with ribose-5-phosphate. Lane 4 contains RpiB kept in 
cacodylate buffer of pH 5.0. Lane 5 contains RpiB kept in cacodylate buffer of pH 7.5. Lane 6 contains RpiB 
kept in cacodylate buffer of pH 6.5. Lane 7 contains a Low Molecular Weight marker, with sizes marked in kDa.   
 
As seen in Figure 10, there are strong bands in lanes containing RpiB kept in cacodylate 
buffer of pH 5.0 with ribose-5-phosphate and RpiB kept in cacodylate buffer of pH 6.5. There 
are weaker bands in lanes containing RpiB kept in cacodylate buffer of pH 7.5 with ribose-5-
phosphate and RpiB kept in cacodylate buffer of pH 7.5. There are no bands in lanes 
containing RpiB kept in cacodylate buffer of pH 6.5 with ribose-5-phosphate and RpiB kept 
in cacodylate buffer of pH 5.0. All bands are just under the 30.0 kDa marker.   
 
Crystallization  
Table 1. The table shows the screens run and their tendency to form clear drops or crystals. 
Run # Screen Buffer Protein 
concentration 
(mg/ml)  
Ligand Precipitant/clear 
drop ratio 
Other 
notes 
#001 Optimum 
solubility 
screen 
Gel 
filtration 
20 No ligand  63/192 
precipitated. 
97/192 clear 
 
#002 PACT Cacodylate 
pH6.0 
10 Ribose-5-
phosphate 
179/192 
precipitated 
13/192 clear. 
 
#003 JSCG+ Cacodylate 
pH 7.0 
5 Ribose-5-
phosphate 
121/192 
precipitated 
70/192 clear  
Crystals 
formed 
after 16 
days. In 
cacodylate 
buffer 
pH7.0 
#004 PACT Cacodylate 
pH 7.0 
5 Allose-6-
phosphate 
176/192 
precipitated 
16/192 clear 
 
#005 PEG/ION Cacodylate 
pH 7.0/pH 
5.0 
5 Ribose-5-
phosphate/ 
Allose-6-
phosphate 
126/192 
precipitated 
66/192 clear  
 
#006 Structure 
screen I 
Cacodylate 
pH 7.5 
4 Ribose-5-
phosphate/ 
177/192 
precipitated 
 
        1       2         3        4        5        6       7       
 
97.0 
 
66.0 
45.0 
 
30.0 
 
 
20.1 
 
14.4 
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Allose-6-
phosphate 
22/192 clear  
#007 Structure 
Screen I 
Hepes pH 8.0/ 
cacodylate pH 
7.0 
2 Ribose-5-
phosphate/ 
Allose-6-
phosphate 
87/192 
precipitated 
106/192 clear  
Stored at 
28oC, 
crystals 
formed after 
48 hours in 
Hepes buffer 
pH 8.0.   
#008 Structure 
Screen I 
Hepes pH 8.0/ 
cacodylate pH 
7.0 
2 Ribose-5-
phosphate/ 
Allose-6-
phosphate 
105/192 
precipitated 
86/192 clear 
 
The first column shows the run number of the plate, where #001 was the first plate run and #008 was the last 
plate run.. The sixth column shows the precipitant and clear drop ratio. Column seven shows any other notes 
important for the results.  
 
The two last crystallization plates were both Structure Screens I, one stored in room 
temperature while the other was stored at 28oC. Both had proteins in buffers of pH 8.0 and pH 
7.0 with either ribose-5-phosphate or allose-6-phosphate added. After 16 hours, long heavily 
twinned needle-shaped crystals had formed in droplets with allose-6-phosphate added, and 
conditions of 0.2 M magnesium acetate tetrahydrate, 0.1M cacodylate, pH 6.5 and 20% PEG 
8000. These poor crystals were used to seed crystals in conditions 0.2 M magnesium acetate 
tetrahydrate, 0.1M Cacodylate pH 6.5 and 20% PEG 8000 but this only gave drops with 
precipitation. The other plate stored in 28oC gave crystals after 48 hours in droplets with 
allose-6-phosphate added, and conditions of 0.2 M calcium acetate hydrate, 0.1 M Na 
cacodylate pH 6.5 and 18% (w/v) PEG 8000. The crystals were taken out of the drop and 
stored in liquid nitrogen. 
 
 Figure 11. A picture of the needle shaped crystals that appeared in the Structure Screen I at room temperature. 
The circular crystals are suspected to be salt.   
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Figure 12. Here are needle shaped crystals from the same drop as in Figure 8 but they are viewed with polarized 
light.  
 
 
Figure 13. This is a picture of the crystals obtained in the Structure Screen I kept at 28oC. The droplet is viewed 
with polarized light.   
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Kinetics  
Ribose-5-phosphate isomerase activity 
Table 2. Results from the first kinetic assay of GlRpiB activity.  
Substrate 
concentration 
(mM) 
Change in 
absorbance 
over 3 
minutes 
Velocity 
(mM/3 
min)  
1/v Average 
1/v 
1/[S] Average 
1/[S] 
[S]/v Average 
[S]/v 
               5       0,0114   0,158333   6,315789             0,2 31,57901 
               5       0,0142   0,197222   5,070423 
5,693106 
              0,2 
0,2 
  25,35214 
28,465575 
  
               6       0,0195   0,270833   3,692308   0,166667 22,15387 
               6       0,0125   0,173611           5,76 
4,726154 
    0,166667 
0,166667 
  34,56002 
28,356945 
  
            7,5       0,018           0,25                4   0,133333 30 
            7,5       0,0151   0,209722   4,768212 
4,384106 
    0,133333 
0,133333 
  35,76163 
32,880815 
  
             10       0,0215   0,298611   3,348837             0,1 33,48838 
             10       0,0159   0,220833   4,528302 
3,9385695 
              0,1 
0,1 
  45,28309 
39,385735 
  
          13,3       0,0195   0,270833   3,692308   0,075188 49,10775 
          13,3       0,0175   0,243056   4,114286 
3,903297 
    0,075188 
0,075188 
  54,7199 
51,913825 
  
             30       0,0268   0,372222   2,686567   0,033333 80,59706 
             30       0,0335   0,465278   2,149254 
2,4179105 
    0,033333 
0,033333 
  64,47758 
72,53732 
  
             40       0,0346   0,480556   2,080925         0,025 83,23692 
             40       0,0426   0,591667   1,690141 
1,885533 
          0,025 
0,025 
  67,6056 
75,42126 
  
             50       0,0266   0,369444   2,706767           0,02 135,3385 
             50       0,0417   0,579167   1,726619 
2,216693 
            0,02 
0,02 
  86,33089 
110,8347 
  
The table shows the values obtained from the kinetic assay of ribose-5-phosphate isomerase activity. The fifth 
column shows the 1/v values for the Lineweaver-Burke plot. The sixth column shows the 1/[S] values for the 
Lineweaver-Burke plot. The seventh column shows the substrate concentration divided by the velocity. The final 
enzyme concentration was 0.0002 mg/ml. The blank measurement was zero.  
 
To convert the change in absorbance over 3 minutes to velocity (mM/3 min). The change in 
absorbance is divided by the extinction coefficient for ribulose-5-phosphate which is 72. For 
example: 
 
Change in absorbance over 3 minutes 0.0114/72 = 0.00015 M => 0.00015 M * 1000 = 0.15 
mM/3 min.   
 
The extinction coefficient for ribose-5-phosphate is very low which gives a small change in 
absorbance over time.  
 
As seen in Table 2 and Figure 12, there is an increase in the velocity of the reaction as the 
substrate concentration increases.  
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Michaelis-Menten plot 
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Figure 14. Michaelis-Menten plot with the velocity on the y-axis and the substrate concentration on the x-axis.  
 
Lineweaver-Burke plot 
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Figure 15. Lineweaver-Burke plot created with the values obtained in the kinetic assay presented in Table 2. The 
x-axis shows 1/Average [S] values and the y-axis shows the 1/Average velocity values. 
 
From the Lineweaver-Burke plot the following kinetic constants were calculated: 
Km = 8.19 mM 
Vmax = 0.18mM/min 
kcat = 262sec-1 
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Hanes-Woolf plot
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Figure 16. A Hanes-Woolf plot made from the data presented in Table 2. On the x-axis average ([S]/v) is 
displayed and on the y-axis the [S] is displayed. 
 
From the Hanes-Woolf plot, the following kinetic constants were calculated: 
Km = 13.3 mM 
Vmax = 0.20 mM/min 
kcat = 291sec-1 
 
Allose-6-phosphate isomerase activity 
Table 3. Results from the second kinetic assay of GlRpiB activity.  
Substrate 
concentra
tion mM 
Absorbance 
at 20 min 
Absorbance at 20 
min with blank 
subtracted 
Velocity 
(mM/min) 
1/[S] 1/v [S]/v 
0 0,35 0 0 0 0 0
0,1 0,46 0,11 0,00019 10 5054,545 505,4545
0,2 0,68 0,14 0,00025 5 3971,429 794,2857
0,3 0,78 0,23 0,00041 3,333333333 2417,391 725,2174
0,5 0,97 0,41 0,00073 2 1356,098 678,0488
1 1,49 0,36 0,00064 1 1544,444 1544,444
2 1,53 0,45 0,00080 0,5 1235,556 2471,111
The table shows the results from the kinetic assay with allose 6-phosphate. The fifth column shows 1/[S]. The 
sixth column shows 1/v. The seventh column shows the substrate concentration divided by the velocity. The 
enzyme concentration was 1.8μM. All the values were obtained from the samples which were left on the heating 
block for 20 minutes.      
 
To convert the absorbance at 20 minutes to velocity (mM/ min), the change in absorbance is 
divided by the extinction coefficient for the Allulose-6-phosphate + TBA product which is 
27800 M and by the time (20 minutes). For example: 
 
Absorbance at 20 min 0.11/27800 = 0.0000039 M => 0.0000039 M * 1000 = 0,0039 mM => 
0,0039 mM/20 min = 0,00019 mM/min 
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Figure 17. Michaelis-Menten plot with the velocity on the y-axis and the substrate concentration on the x-axis. 
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Figure 18. Lineweaver-Burke plot created with the values obtained in the kinetic assay presented in Table 3. The 
x-axis shows 1/[S] values and the y-axis shows the 1/v values.  
 
From the Lineweaver-Burke plot the following kinetic constants were calculated: 
Km = 0.41mM 
Vmax = 0.0009 mM/min 
kcat = 0.008sec-1 
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Figure 19. A Hanes-Woolf plot made from the data obtained in Table 2. On the x-axis, [S]/v is shown and on the 
y-axis the [S] is shown. 
 
Km = 0.41mM 
Vmax = 0.0009 mM/min 
kcat = 0.008sec-1 
 
Inhibitor tests 
Table 4. Results from inhibitor test.   
Tube content 
Final [I]: 10mM, 
Final [S]: 5mM  
Change in absorbance  
during a period of 180 
seconds 
Average Change in 
absorbance during a 
period of 180 seconds 
Enzyme blank 0  
4PEH 0.00084 0.0021 
4PEH 0    
4PEH 0.0056   
Without inhibitor 0.0112 0.0106 
Without inhibitor 0.0058   
Without inhibitor 0.0148   
5PRGly 0.0092   
5PRGly 0.0093   
Without inhibitor 0.0100 0.0099 
Without inhibitor 0.0100   
Without inhibitor 0.0098   
4PEHz 0.0130 0.0133 
4PEHz 0.0100   
4PEHz 0.0170   
Without inhibitor 0.0083 0.0097 
Without inhibitor 0.0100   
Without inhibitor 0.0110   
5PRA/5PRH 0.0110 0.0101 
5PRA/5PRH 0.0097   
Without inhibitor 0.0096 0.0110 
Without inhibitor 0.0104   
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5PRAm 0.0132 0,0115 
5PRAm 0.0112   
Without inhibitor 0.0102 0,0076 
Without inhibitor 0.0105   
5PRMA 0.0111   
5PRMA 0.0104   
Without inhibitor 0.0105 0,0106 
Without inhibitor 0.0103   
Without inhibitor 0.0112   
The table displays the change in absorbance over 180 seconds to it correspondent inhibitor. The first column 
contains the test tube content and the second column contains the change in absorbance during a period of 180 
seconds. 5PRA and 5PRH amounts were limiting so only duplicates are shown for that measurement and both 
inhibitors were run at the same time.  
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Figure 20. A bar diagram displaying the inhibitors’ effects. The y-axis shows the average change in absorbance 
over 180 seconds. The x-axis shows the values for the inhibitor and a corresponding measurement without 
inhibitor. The box to the right shows which staple corresponds to what inhibitor. The staple to the right of the 
inhibitor staple is the blank without inhibitor which is needed to see if the inhibitor works.    
 
As seen in Table 4, the change in absorbance without inhibitor is about 0.0100 during a period 
of 180 seconds. The final concentration of inhibitor was 10mM. The final concentration of 
enzyme was 0.0002 mg/ml (0.0114 μM). The first six samples had a final substrate 
concentration of 5 mM while the other samples had a final concentration of 10 mM. It was 
decided to increase the substrate concentration because if the change in absorbance would 
become smaller it could be too little to measure. There are only duplicates of SPRAM because 
the amount of inhibitor available was limited. The only inhibitor that seems to have a great 
affect on the change in absorbance was 4PEH.     
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Discussion 
During the concentration of protein at pH 6.0 during the second purification, the protein 
precipitated in the Vivaspin tube and therefore not all of the protein could be recovered which 
gave a smaller yield. It thus seems that the protein is more soluble in higher pHs. 
 
As seen in Figure 4, there were two peaks eluted from the gel filtration column. The higher 
peak had a calculated size of 33.7 kDa which is about the size of the dimer of GlRpiB which 
is 35 kDa. In the second purification as seen in Figure 5, using the same column the higher 
peak had an estimated molecular weight of 45.7 kDa, which is much larger than the dimer. 
The smaller peak has a molecular weight of 110.2 kDa. In both purifications there was an 
small peak which was at a larger size than the dimer. The small peaks with the large 
molecular weights could be explained by inclusion bodies which would not be soluble but sill 
have a His-tag and thus get stuck to the nickel column and eluted with GlRpiB.  
 
The gel seen in Figure 7 shows GlRpi B in fractions 25 to 21. Figure 8 the protein is present 
in fractions 26 and 27 which corresponds to the largest (dimer) peak in the gel filtration peak 
in Figure 2. In Figure 9, lane 1 has a band at the right for GlRpi B which indicates that the 
protein in the second purification is also of the right size. The native gel (see Figure 10) 
indicates that the protein is a homogeneous dimer as all of the bands are ≈ 30.0 kDa (GlRpiB 
= 17804 Da with His-tag construct).  
 
By looking at Table 1 it is very clear that the protein crystallizes in higher pH and that crystals 
form earlier in higher temperature than room temperature. Cacodylate seems to be needed to 
form crystals as in every condition crystals formed cacodylate was present. The crystals in 
Figure 11 were sent to the synchrotron in Grenoble but the resolution of the data obtained 
(≈3Å) was too low to solve the structure of the protein.  
 
The plot in Figure 14 for ribose-5-phosphate isomerase activity dose not have the ideal shape 
of a Michaelis-Menten plot but dose generally follow the expected pattern. The Lineweaver-
Burke plot does not look strange but the Km is 8.2 mM which is high compared to 
Trypanosoma cruzi (which also is a parasitic protozoa) Rpi B which in the study made by Ana 
L. Stern et al has a Km of 4mM. Compared to the RpiB from the slow growing parasite 
Mycobacterium tuberculosis (Km = 3.7mM) the GlRpiB Km is also high (Roos et al 2004). 
When the values were placed in a Hanes-Woolf plot all values increased. The kcat values in 
both the Hanes-Woolf and the Lineweaver-Burke are very large. It is about twice as large as 
the kcat for MtRpiB (kcat = 120sec-1) with ribose-5-phosphate (Roos et al 2004). Because no 
structure has been solved for GlRpiB it is hard to speculate if the structure might affect the 
high Km and kcat values.   
 
The plot for the kinetic assay with allose-6-phosphate is seen in Figure 17, is a better fit to the 
Michaelis-Menten equation. The values obtained from the Hanes-Woolf plot are identical to 
the values obtained from the Lineweaver-Burke plot which strengthens one’s trust in the 
kinetic values. Because of the high Km obtained in the kinetic assay were ribose-5-phosphate 
is used as a substrate indicates that the protein does not prefer to work with ribose-5-
phosphate. In fact, in the parasite could use RpiB to produce ribulose-5-phosphate from 
ribose-5-phosphate.     
 
As seen in Table 4 and Figure 20, 4PEH (4-phospho-D-erythronohydroxamic acid) is the only 
inhibitor that differs significantly in the test with and without inhibitor. As seen in figure 2 
4PEH is very similar to ribose-5-phosphate except that it has a four carbon back bone while 
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ribose has a five carbon and 4PEH has a NH-OH group bound to it. The inhibitor 5PRH has 
the same group bound but it has a five carbon back bone (as seen in figure 3) which would 
inhibit the reaction allose-6-phosphate/allulose-6-phosphate but when looking at the numbers 
in Table 4 there is only a small change in the absorbance between the samples with inhibitor 
and without inhibitor. Because the small change in 5PRH it can not be concluded that the NH-
OH group is the single factor that determines whether the compound inhibits the protein. The 
reason for 5PRH low change in absorbance between samples with and without inhibitor could 
be because it is a six carbon sugar and is placed differently in the protein and therefore the 
NH-OH group is placed wrong in the active site. 
 
What can be concluded from the results is that the protein precipitates in lower pHs as seen in 
table 1 were screens with lower pHs had more precipitated drops than clear. The tests showed 
that the protein has a higher Km and kcat compared to other parasites that infect humans. The 
inhibitory test showed that the compound that inhibited the enzyme reaction with the greatest 
effect from the compounds tested was 4PEH as it lowered the average change in absorbance 
compared to the control without inhibitor (as seen in table 4 and figure 20). Therefore 4PEH 
is the best compound to develop as an agent against Giardia lamblia infection from the 
compounds tested.      
 
Further work 
For further work calculating the Ki for 4PEH would be of great importance as it will tell one if 
the inhibitor is competitive, non-competitive or uncompetitive. After the Ki of the inhibitor 
has been determined the chemical structure of 4PEH has to be changed as it will not be taken 
up by the parasite because of the phosphate group bound to it. When one knows that the 
compound will taken up by the parasite initial drug test can take place.   
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Appendix  
 
Buffers: 
Lysis buffer: 
• 50 mM NaH2PO4 (pH8) 
• 300 mM NaCl 
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• 10 mM Imidazole 
• 1% (v/v) Glycerol  
• 400 mM phenylmethylsulfonyl fluoride (Serine protease inhibitor) 
• 1 mM β-mercaptoethanol  
 
Wash buffer 1: 
• 50 mM NaH2PO4 (pH8) 
• 300 mM NaCl 
• 50 mM Imidazole  
• 1% (v/v) Glycerol  
 
Wash buffer 2: 
• 50 mM NaH2PO4 (pH 8) 
• 300 mM NaCl 
• 100 mM Imidazole 
• 1% (v/v) Glycerol 
 
Elution buffer: 
• 50 mM NaH2PO4 (pH 8) 
• 300 mM NaCl 
• 300 mM Imidazole 
• 1% (v/v) Glycerol 
• 10 mM β-mercaptoethanol 
 
Gel filtration buffer:  
• 20 mM Tris HCl (pH 7.5) 
• 150 mM NaCl 
• 1% v/v Glycerol 
• 10 mM β-mercaptoethanol 
• 1 mM EDTA 
 
Cacodylate buffer: 
• 20 mM Cacodylate, pHs: 5.0, 6.0, 6.5, 7.0, 7.5 
• 150 mM NaCl 
• 1% v/v Glycerol 
• 10 mM β-mercaptoethanol 
 
Hepes buffer: 
• 5 mM β-mercaptoethanol 
• 150 mM NaCl 
• 20 mM Hepes pH 8.0 
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Incubation buffer 
• 50 mM TrisHCl pH 7.6; 5 mM  
• MESNA 
Raw data 
 
Gel filtration chromatography  
 
Table 5. Gel filtration chromatography calibration and results. 
Protein 
Molecular Weight 
(Da) Ve (ml) LogMW Kav 
Ribonuclease A 15600 76,2 4,1931 0,4233
ChymotrypsinogenA 20400 68,6 4,3096 0,3246
Ovoalbumin 48100 57,7 4,6821 0,1831
Albumin 63500 53,5 4,8028 0,1285
Large peak in Figure 1 31600 63,9 4.4997 0,2636
Small peak in Figure 1 77326 50 4,8883 0,0831
Large peak in Figure 2 43876 58.8 4.6422 0,1974
Small peak in Figure 2 110235 44,5 5,0423 0,0116
The table shows proteins used to calibrate the HiLoad Superdex 75 preparative grade column and the peaks with 
corresponding molecular weights, elution volumes, Log molecular weight and Kav values.  
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Figure 19. The figure is a graph used for calculating the Log molecular weight from the Kav by using the 
equation of the trendline. Series 1 is made up by the proteins ribonuclease A, Chymotrypsinogen A, ovalbumin 
and albumin.  
 
Kav = Ve-Vo/Vt-Vo  
 
Vo = 43.6 ml 
Vt = 120.6 ml 
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Vt-Vo = 77 ml  
 
Large peak in Figure 1  
Kav = 63.9 ml - 43.6 ml/120.6 ml – 43.6 ml 
Kav = 0.2636 
 
y = -2.1533x + 5.0673 
y = -2.1533 * 0.2636 + 5.0673 
y = 4.4997 
Log MW = 4.4997 => 104.4997 = 31.6 kDa 
 
Small peak in Figure 1 
Outside calibration range 
 
Large peak in Figure 2 
Kav = 58.8 ml - 43.6 ml/120.6 ml – 43.6 ml 
Kav = 0,1974 
 
y = -2.1533x + 5.0673 
y = -2.1533 * 0,1974 + 5.0673 
y = 4.6422 
Log MW = 4.6422 => 104.6422 = 43.8 kDa  
 
Small peak in Figure 2 
Outside calibration range 
Concentration and yield of protein  
First purification: 
Absorbance of 0.733/0.04 μg/ml = 18.325 μg => 18.325 μg/0.22 μl = 83μg/μl = 83mg/ml 
 
The absorbance is divided with the Bradford constant (0.04 μg/ml) which gives the amount of 
protein in the 1ml of Bradford dye solution (18.325 μg). The amount of protein is divided by 
the real volume of protein (0.22 μl) which gives the initial protein concentration.    
 
Yield = 83mg/ml * 0.2 ml = 16.6mg => 16.6mg/0.8l L = 20mg protein/L of cell culture 
 
To get the yield the concentration is multiplied by the amount of purified sample (0.2 ml) and 
then divided by the amount of cell culture (0.81 L). This gives the amount of protein from one 
liter of cell culture. Because the sample in the second purification was divided into two 
batches one with cacodylate buffer at pH 7.0 and one with cacodylate buffer at pH 6.0 the 
amount of purified sample has to be multiplied by two.   
 
Second purification:  
pH 7.0: absorbance of 0.342/0.04 μg/ml = 8.55 μg => 8.55 μg/0.1 μl = 86 μg/μl = 86 mg/ml 
 
Yield = 86mg/ml * 0.2 ml = 17.2 mg => 17.2 mg * 2 = 34.4 mg/0.81 L = 42.5mg of protein/L 
of cell culture 
 
pH 6.0: absorbance of 0.114/0.04 μg/ml = 2.85μg => 2.85μg/0.1μl = 29μg/μl = 29mg/ml 
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Yield = 28.5mg/ml * 0.2 ml = 5.7mg => 5.7mg * 2 = 11.4 mg/0.81 L = 14 mg of protein/L of 
culture   
 
Kinetics: 
 
Km and Vmax can be calculated from the lineweaver burk plot. If 1/[S] is plotted on the x-axis 
and 1/velocity is plotted on the y-axis, -1/Km is were the line crosses the x-axis. Which means 
that if y = 0 in the line equation of the plot then x = -1/Km. 1/Vmax is were the line crosses the 
y-axis. Which means that if x = 0 in the line equation of the plot then y = 1/Vmax.  
 
   
Figure 20. A Limeweaver plot showing were the -1/Km and 1/Vmax can be calculated from with 1/velocity on the 
y-axis and 1/[S] on the x-axis (Wikipedia1).   
 
Km and Vmax can also be calculated by using a Hanes-Woolf plot. If the [S] is plotted on the x-
axis and [S]/v is plotted on the y-axis, -Km is were the line crosses the x-axis and 1/Vmax is the 
angel of the slope. If y = 0 in the line equation of the plot then x = -Km. Hanes-Woolf plots are 
often considered less sensitive as the substrate concentration is present on both axis.  
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Figure 21. A Hanes-Woolf plot showing were –Km and 1/Vmax can be calculated from with the substrate 
concentration on the x-axis and the substrate concentration divided by the velocity on the y-axis (wikipedia 2).  
 
Ribose-5-phosphate: 
 
Km, Vmax and kcat using the Lineweaver-Burke plot (Figure 15) 
Km: y = 19.251x + 1.8324 => 0 = 19.251x + 1.8324 => x = -0.0951 => -1/-0.0951 = 10.5 mM 
 
Vmax: y = 19.251x + 1.8324 => y = 19.251 * 0 + 1.8324 => y = 1.8324 => 1/1.8324 = 0.54 
mM/3 min = 0.18 mM/min 
 
The final concentration of enzyme in the cuvette was: 0.0002mg/ml. 
[E]: 0.0002 mg/ml /17500 Da = 1.142 * 10-8 M => 1.142 * 10-8 M * 1000 = 0.00001142 mM   
 
kcat = Vmax/[E] 
kcat: 0.18 mM/min /0.00001142 mM = 15761 min-1 => 15761 min-1/60 = 262sec-1  
 
Km, Vmax and kcat using the Hanes-Woolf plot (Figure 16) 
Km: y = 1.6417x + 21.771 => 0 = 1.6417x + 21.771 => x = -13.2612 => -1*-0.1221 = 13.3 
mM 
 
Vmax: y = 1.6417x + 21.771 => 1/1.6417 = 0.61 mM/3 min => 0.20 mM/min 
 
kcat = Vmax/[E] 
kcat: 0.20 mM/min/0.00001142 mM = 17513 min-1 => 17513 min-1/60 = 291sec-1 
Allose-6-phosphate: 
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Km, Vmax and kcat using the Lineweaver-Burke plot (Figure 17) 
Km: y = 430.34x + 1030.6 => 0 = 430.34x + 1030.6 => x = -2.3948 => -1/-2.3948 = 0.41 mM 
 
Vmax: y = 430.34x + 1030.6 => y = 430.34 * 0 + 1030.6 => y = 1030.6 => 1/1030.6 = 0.0009 
mM/min 
 
The final concentration of enzyme in the cuvette was: 1.8 μM  
[E]: 1.8 μM/1000 = 0.0018 mM  
 
kcat = Vmax/[E] 
kcat: 0.0009 mM/min/0.0018 mM = 0.5min-1 => 0.5min-1/60 = 0.008sec-1    
 
Km, Vmax and kcat using the Hanes-Woolf plot (Figure 18) 
Km: 0 = 1028.3x + 417.07 => x = -0.4055 => -1*-0.4055 = 0.41 
 
Vmax: 1/417.07 = 0.0009 
 
The final concentration of enzyme in the cuvette was: 1.8 μM  
[E]: 1.8 μM/1000 = 0.0018 mM 
 
kcat = Vmax/[E] 
kcat: 0.0009 mM/min/0.0018 mM = 0.5min-1 => 0.5min-1/60 = 0.008sec-1    
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